Intelligence coverage: 70%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

IFRX

InflaRx N.V.

Healthcare · Pharmaceuticals

$1.82Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

InflaRx N.V. execution reads as mixed on proprietary earnings and initiative evidence.

ExecutionMixed

3 signals not yet derived from pipeline evidence

Pipeline evidence · 0d ago

IFRX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on IFRX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for InflaRx N.V. (IFRX) — events, not interpretation.

Event
Last session September 28, 2026 at $1.82.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

InflaRx N.V. (IFRX)

Healthcare · Pharmaceuticals

Investment Snapshot above is the primary AlphaOS analysis for InflaRx N.V. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$131.57M

IFRX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow InflaRx N.V. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.